Tag: preclinical
-
GSK, Alphabet Form Bioelectronic Device Venture
Drug maker GlaxoSmithKline, or GSK, and Verily Life Sciences, a division of Alphabet, the parent company of Google, are forming a joint venture to develop miniaturized therapeutic electronic devices.
-
Open-Source Discovery Yields Anti-Malaria Candidates
A worldwide research project tested 400 compounds as anti-malarial drugs, which led to more than 30 new drug development programs for malaria and other diseases.
-
Trial Underway Testing Stem Cells to Treat Alzheimer’s
An intermediate-stage clinical trial is recruiting participants to test donated stem cells as a treatment for mild-moderate dementia from Alzheimer’s disease.
-
Nanoparticles, Peroxide Boost Tooth Decay Prevention
Adding iron oxide nanoparticles to hydrogen peroxide is shown to reduce the build-up of bacterial films on teeth, preventing cavities from forming in lab rats.
-
Patch Delivers Gene, Drug, Heat Therapies to Colon Tumors
Engineers developed a hydrogel patch with three types of therapy applied directly to tumors in the colon, which in lab mice caused cancer to go into remission.
-
Device Measuring Nerves on Heart Rhythm in Development
22 July 2016. A spin-off enterprise from Indiana University is creating a device to measure sympathetic nerve activity — the fight-or-flight response — in people with heart rhythm disorders. Research and development of a prototype device, by Arrhythmotech LLC in Indianapolis, is funded by a new 2-year, $1.47 million grant from National Institute of Drug…
-
Refillable HIV Prevention Implant in Development
A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute.
-
New Leukemia Target, Drug Candidate Discovered
An industry-academic research team identified a new target for acute myeloid leukemia, and tested a new drug that stops the growth of these cancer cells.
-
RNA Technology Allows for Fast Vaccine Development
Engineers at MIT designed a process using genetic material in nanoscale particles for vaccines that protected against dangerous diseases with a single dose.
-
Bacterial-Biopolymer Delivery System Designed for Vaccines
A biotechnology company and university lab developed a vaccine delivery technique that induces an immune response, combining bacteria and a polymer material.